ALTAIR NANOTECHNOLOGIES INC.

thermotech subroutine

In general, Altair is, and expects to be in the
immediate future, dependent upon funds generated from sales of securities ,
grants, testing agreements, and licensing agreements to fund its testing,
development and ongoing operations. (Pink Sheets:LQMT) today announced it will release
financial results for the three months ended March 31, 2005 at
approximately 4:00 pm (EDT) on Wednesday, May 11, 2005. These statements
involve risks and uncertainties that could cause actual outcomes and
results to differ materially from the anticipated outcomes or result,
and undue reliance should not be placed on these statements .

thermotech anisotropy

Altair Nanotechnologies, through product innovation, is a leading supplier
of advanced ceramic nanomaterial technology worldwide. On January 31, 2005 Altair licensed their RenaZorb
drug candidate to a California-based pharmaceutical company for human
therapeutic and diagnostic applications to develop, market and sell the
RenaZorb product line for End Stage Renal Diseases (ESRD).

superconductors thermoset

265
during a four year term, and is subject to one demand registration right
and unlimited incidental registration rights. The Performance Materials Division is pursuing market
applications in Advanced Materials for paints and coatings; titanium metal
manufacturing, catalysts and water treatment; and alternative energy.com) is the
leading developer, manufacturer, and marketer of products made from
amorphous alloys.

semiconductors abaqus

companyboardroom.

marketech thermosetting

As consideration, Maxim Group LLC is entitled to receive a
cash fee equal to 5% of the gross proceeds from the offering and a warrant
to purchase 250,000 shares of common stock at an exercise price of $5. The
company has a scalable manufacturing capability to meet emerging
nanomaterials demands, with capacity today to produce hundreds of tons of
nanomaterials.altairnano . In addition, other risks are
identified in the company's most recent Annual Report on Form 10 -K, as
filed with the SEC. These
risks and uncertainties include: unforeseen events that could further
delay completion of the company's ongoing audit process; pending
litigation against the company and its potential outcome; our limited
operating history in developing and manufacturing products from bulk
amorphous alloys; the adoption of our alloys by customers; the
commercial success of our customer's products; our ability to
identify, develop, and commercialize new applications for our alloys;
competition with suppliers of incumbent materials; the development of
new materials that render our alloys obsolete; the ability to manage
our anticipated growth; our limited direct experience in manufacturing
bulk alloy products; scaling-up our manufacturing facilities;
protecting our intellectual property; problems associated with
manufacturing and selling our alloys outside of the United States; and
other risks and uncertainties discussed in filings made with the
Securities and Exchange Commission (including risks described in
subsequent reports on Form 10-Q, Form 10-K , Form 8-K, and other
filings).

Material science is concerned with understanding the properties of materials and how to create new ones.

cryotechnology elastomers

The proceeds will be used for general corporate purposes , including, but
not limited to, working capital, capital expenditures, research and
development activities and the acquisition of other technologies.

Forward-Looking Statements

This release may contain forward-looking statements as well as historical
information.com or at
http: //www.

multicomponent superconductors

Amorphous alloys are unique materials that are
characterized by a random atomic structure, in contrast to the
crystalline atomic structure possessed by ordinary metals and alloys.

This press release may contain "forward-looking statements" that
involve risks and uncertainties, including statements regarding our
anticipated financial results, as well as our plans, future events,
objectives , expectations, forecasts, and the assumptions on which
those statements are based.

modulus semiconductors

Altair
Nanotechnologies ' unique team of material scientists who, coupled with
collaborative ventures with industry partners and leading academic centers,
has pioneered an impressive array of intellectual property and product
achievements. The company expressly disclaims any obligation to
update or revise any forward -looking statements found herein to reflect any
changes in company expectations or results or any change in events.----Liquidmetal(R)
Technologies Inc.com
The dial-in-number to access this operator -assisted call is toll
free 1-800-289-0494 or toll 1-913-981-5520 for International callers.

elastomers crystalline

(NASDAQ: ALTI)
announced today that it has entered into definitive agreements with respect
to the sale of five million shares of its common stock to institutional
investors at a price of $4. And on
February 10, 2005 Altair announced it has achieved a breakthrough in
Lithium battery electrode materials that could enable a new generation of
rechargeable batteries to be introduced into the marketplace, as well as
create new markets for rechargeable batteries. Liquidmetal
Technologies will host a conference call at 4:30 pm (EDT) that day to
discuss the results.

subroutine marketech

05 per share, for gross proceeds of
approximately $20,250,000. These risks and
uncertainties include, without limitation , the risks that closing will not
occur for one of various reasons, including the failure of Altair or the
investors to satisfy conditions to closing, the failure of the investors to
fund or the issuance of a stop order by a governing regulatory body; that
Altair's numerous development stage products, including its
development-stage Lithium battery electrode materials, will not be
developed to the point of commercialization or that, even if
commercialized, no market will exist for such products or Altair will fail
to effectively market to customers in a market: the risks that Altair will
be unable to enter into license agreements regarding its pigment process
(AHPP), its TiNano Sphere or other developing products, that even if Altair
enters into such license agreements, short term revenues from such
agreements will not be sufficient to fund Altair's operations in the long
run, and that animal testing or future testing of RenaZorb or other
products of the company will not be successful and that development will
need to be terminated.

anisotropy tabulated

Altair Nanotechnologies has developed robust proprietary technology
platforms for manufacturing a variety of crystalline and non-crystalline
nanomaterials of unique structure, performance, quality and cost.liquidmetal .
Bulk Liquidmetal(R) alloys are two to three times stronger than
commonly used titanium alloys , harder than tool steel, and relatively
non-corrosive and wear resistant.

ansys marketech

With the completion of
the placement, Altair will have 56,794,724 shares of common stock issued
and outstanding. Maxim Group LLC is acting as placement agent for the
transaction.com

About Liquidmetal Technologies

Liquidmetal Technologies (http://www.

ansys superalloys

The Life Sciences Division is pursuing market applications in
pharmaceuticals, drug delivery, dental materials, cosmetics and other
medical markets. For additional
information on Altair and its nano-materials, visit www.
Institutional investors can also access the call via CCBN's
password-protected event management site, StreetEvents
http:/ /www.

cryotechnology thermotech

Business Editors

LAKE FOREST, Calif.
Listeners may access the conference call live over the Internet
from Liquidmetal Technologies' website http://ir.

texture superalloys

Forward-looking statements , which are included in accordance
with the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995, may involve risks, uncertainties and other factors that
may cause the company 's actual results and performance in future periods to
be materially different from any future results or performance suggested by
the forward-looking statements in this release.

Liquidmetal Technologies Announces First Quarter Earnings Release Date and Conference Call

Liquidmetal Technologies disclaims any intention or
obligation to update or revise any forward-looking statements, whether
as a result of new information, future events, or otherwise.

semiconductors superalloys

, Altair Nanomaterials,
TiNano, RenaZorb, NanoCheck , TiNano Spheres and the Altair
Hydrochloride Pigment Process are trademarks or registered trademarks of
Altair Nanotechnologies, Inc.

thermodynamic abaqus

liquidmetal.

multicomponent marketech

com

Altairnano, Altair Nanotechnologies , Inc. Liquidmetal
Technologies is the first company to produce amorphous alloys in
commercially viable bulk form, enabling significant improvements in
products across a wide array of industries .

elastic superconductors

Following closing of the financing, which is
expected to occur today, Altair expects to receive approximately
$19,237,500 after deducting all fees and expenses. The combination of a super
alloy 's performance coupled with unique processing advantages
positions Liquidmetal alloys for what the company believes will be The
Third Revolution(TM) in material science.

thermotech elastic

The company is organized into two divisions: Life Sciences and Performance
Materials. Many
of the product technology initiatives that the company has been working on
in past years are now coming to the commercialization stage.

alumina superconductors

Such forward-looking statements speak only as of the
date of this release.

conductivity thermotech

PRESS RELEASE Altair Nanotechnologies Inc. Announces Shelf Registration Closing

Bulk Liquidmetal alloys can also be
molded into precision net-shaped parts similar to plastics, resulting
in intricate and sophisticated engineered designs.

conductivity anisotropy

Altair scientists apply their nanomaterials science and know how to solve
real world needs.streetevents.

abaqus thermodynamic

Altair Nanotechnologies, Inc. Any statement in this press release that
is not a statement of historical fact is a forward-looking statement,
and in some cases, words such as "believe," "estimate," "project,"
"expect," "intend," "may," "anticipate," "plans, " "seeks," and similar
expressions identify forward-looking statements.